Zoekresultaten - 6 results
Molecular test algorithms for breast tumours
13, Issue 2, Number 45 (2019) Abstract: In order to advise the Federal Government on all matters related to personalised medicine in oncology, including the reimbursement of molecular tests, the ...
The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer
socio-professional support. Methods: We requested data from the Belgian Cancer Registry and the Crossroad Bank for Social Security. We included all socially insured Belgian workers diagnosed between 2004 and 2011 with ...
Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.
a clinician sample; and verification of the presence of cervical intraepithelial neoplasia grade 2 or worse (CIN2 +) by colposcopy and biopsy in all enrolled women or in women with positive tests. Participation ...
Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials.
types and women unselected by HPV status. Expert commentary: All evaluated vaccines offered excellent protection against cervical intraepithelial neoplasia of grade 2 or 3 (CIN2 or CIN3) and ...
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
specificity of 1.00 (95% CI, 0.99 to 1.01) (value of >0.05 in all cases). Regardless of the clinical outcome (CIN2 + or CIN3 +), age restriction (women ≥30 years old), or comparator test used, Anyplex ...
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples
particular devices before collection of a cervical sample by a clinician. Sample sets are subsequently analysed in a laboratory accredited for HPV testing. Disease verification for all enrolled patients is ...